I think one of the tricks used in these kinds of papers is that they're intentionally using obscuring language. That being said, I doubt their sample sizes are large enough to be really meaningful. BUT, my guess is they will say this anti-HepB activity is because HepB is said to use reverse transcription activity also. But to me the infuriating thing is that the complex edifice of virology obscures that's likely actually going on at a cellular level. Meaning I think these drugs are doing nothing more than interfering with signals read as these viruses. It's all smoke and mirrors.
"At the 12-month of follow-up, no incident HBV infections occurred in the F/TDF users group, and only one incident HBV infection occurred in the F/TDF non-users group."
In other words, 'heads I win, tails you lose'? What am I missing?
Hey Rebecca, I just became aware of something here on substack you might be interested in that directly relates to 'HIV' drugs not being specific. Someone posted a Q&A style document the Perth Group released to a forum group a decade or so ago, and was just published on this substack. Eleni specifically addresses questions about 'ARVs' being non-specific.
I think one of the tricks used in these kinds of papers is that they're intentionally using obscuring language. That being said, I doubt their sample sizes are large enough to be really meaningful. BUT, my guess is they will say this anti-HepB activity is because HepB is said to use reverse transcription activity also. But to me the infuriating thing is that the complex edifice of virology obscures that's likely actually going on at a cellular level. Meaning I think these drugs are doing nothing more than interfering with signals read as these viruses. It's all smoke and mirrors.
Keep hoping, girl…and this boy will keep hoping, too ;-)
"At the 12-month of follow-up, no incident HBV infections occurred in the F/TDF users group, and only one incident HBV infection occurred in the F/TDF non-users group."
In other words, 'heads I win, tails you lose'? What am I missing?
Hey Rebecca, I just became aware of something here on substack you might be interested in that directly relates to 'HIV' drugs not being specific. Someone posted a Q&A style document the Perth Group released to a forum group a decade or so ago, and was just published on this substack. Eleni specifically addresses questions about 'ARVs' being non-specific.
https://longtimedissident.substack.com/p/new-the-perth-groups-advice-to-positive